Friday 25th September 2026 13:00 - 14:00 (BST)
Generics, Branded Generics and Biosimilars continue to play a critical role in delivering value across the NHS, supporting both cost containment and equitable patient access. As the system moves through 2026, their importance is only increasing amid financial pressure, service recovery demands and a renewed focus on productivity.
In this 60-minute masterclass, our expert panel will examine how national policy shifts, evolving commissioning approaches and increased scrutiny on medicines value are reshaping the competitive landscape. With greater emphasis on efficiency and outcomes, these product categories are being positioned as key enablers of NHS sustainability.
You’ll gain an updated view of pricing pressures, procurement frameworks and market access dynamics, alongside insight into how Integrated Care Systems (ICSs) and provider collaboratives are influencing uptake and decision-making at a local level.
Whether you’re responsible for portfolio strategy, market access or account engagement, this session will help you understand how to navigate increasing complexity while identifying new opportunities to demonstrate value and strengthen your positioning.
25th Sep 2026 13:00 – 14:00 (BST)
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now